The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
The Anticancer Properties of Salvia Miltiorrhiza Bunge (Danshen): A Systematic Review
Abstract
Salvia miltiorrhiza Bunge (Danshen in Chinese) is a classical Huoxue Huayu (a traditional Chinese medical term means promoting blood circulation and removing blood stasis) herb with 1000 years of clinical application. It mainly contains two groups of ingredients: the hydrophilic phenolic acids and the lipophilic tanshinones. Both groups have demonstrated multiple bioactivities, such as antioxidative stress, antiplatelet aggregation, anti‐inflammation, among others. Recent data have demonstrated that its lipophilic compounds, especially the tanshinones, show potent anticancer activities both in vitro and in vivo. The anticancer effects of the hydrophilic phenolic acids have also been reported. Furthermore, tanshinones provide structural skeletons for chemical modifications, allowing for a series of derivatives of interests. This review provides a systematic summary of the anticancer profile and the underlying mechanisms of the bioactive compounds isolated from Danshen with special emphasis on tanshinones, aiming to bring new insights for further research and development of this ancient herb.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836
Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use
Zhou, L., Zuo, Z., & Chow, M. S. S. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005282630 · Cited by 1,274
Cardiovascular effects of Danshen
Cheng, T. O. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.01.004 · Cited by 439
A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs
Sun, Y., Xun, K., Wang, Y., & Chen, X. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328330d95b · Cited by 417
Self-citationCardiovascular actions and therapeutic potential of tanshinone IIA
Gao, S., Liu, Z., Li, H., Little, P. J., Liu, P., & Xu, S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.041 · Cited by 359
Shin, D.-S., Kim, H.-N., Shin, K. D., Yoon, Y. J., Kim, S.-J., Han, D. C., & Kwon, B.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2575 · Cited by 309
Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection
Ho, J., & Hong, C.-Y. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-30 · Cited by 292
Potential anticancer activity of tanshinone IIA against human breast cancer
Wang, X., Wei, Y., Yuan, S., Liu, G., Lu, Y., Zhang, J., & Wang, W. (2005) · International Journal of Cancer · doi:10.1002/ijc.20880 · Cited by 237
Dong, Y., Morris-Natschke, S. L., & Lee, K.-H. (2011) · Natural Product Reports · doi:10.1039/c0np00035c · Cited by 228
Terpenoids as Potential Anti-Alzheimer’s Disease Therapeutics
Yoo, K.-Y., & Park, S. (2012) · Molecules · doi:10.3390/molecules17033524 · Cited by 169
Epigenetic regulation and cancer (Review)
CHEN, Q. W., Zhu, X., Li, Y., & Meng, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2913 · Cited by 168
Anticancer effects of tanshinone I in human non-small cell lung cancer
Lee, C.-Y., Sher, H.-F., Chen, H., Liu, C.-C., Chen, C., Lin, C., Yang, P., Tsay, H.-S., & Chen, J. J. W. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2288 · Cited by 126
Gong, Y., Li, Y., Lu, Y., Li, L., Abdolmaleky, H. M., Blackburn, G. L., & Zhou, J. (2010) · International Journal of Cancer · doi:10.1002/ijc.25678 · Cited by 124
Tang, S., Shen, X., Huang, H., Xu, S., Yu, Y., Zhou, C., Chen, S., Le, K., Wang, Y., & Liu, P. (2010) · Inflammation · doi:10.1007/s10753-010-9214-3 · Cited by 124
Self-citationSung, H. J., Choi, S. M., Yoon, Y., & An, K. S. (1999) · Experimental & Molecular Medicine · doi:10.1038/emm.1999.28 · Cited by 120
Lin, C., Wang, L., Wang, H., Yang, L., Guo, H., & Wang, X. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24553 · Cited by 108
Chen, W., Luo, Y., Liu, L., Zhou, H., Xu, B., Han, X., Shen, T., Liu, Z., Lu, Y., & Huang, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0020 · Cited by 107
Lee, W., Liu, K. W. K., & Yeung, J. H. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.040 · Cited by 103
Yoon, Y., Kim, Y., Jeon, W.-K., Park, H.-J., & Sung, H. J. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(99)00059-8 · Cited by 99
Nizamutdinova (1992) · International Journal of Oncology · doi:10.3892/ijo_00000031 · Cited by 99
Liu, F., Yu, G., Wang, G., Liu, H., Wu, X., Wang, Q., Liu, M., Liao, K., Wu, M., Cheng, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042138 · Cited by 93
Won, S., Lee, H., Jeong, S., Lee, H.-J., Lee, E., Jung, D., Shin, J.-M., Kwon, T., Yun, S.-M., Lee, M., et al. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1828 · Cited by 91
Wu, K., Zhang, Q., Liu, Q. S., Tang, F., Long, Y., & Yao, S. (2009) · Journal of Separation Science · doi:10.1002/jssc.200900398 · Cited by 91
Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro
Hur, J.-M., Shim, J. S., Jung, H. J., & Kwon, H. J. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.18 · Cited by 87
Park, I.-J., Kim, M., Park, O. J., Park, M. G., Choe, W., Kang, I., Kim, S. S., & Ha, J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.06.006 · Cited by 86
Yun, S., Jung, J. H., Jeong, S., Sohn, E. J., Kim, B., & Kim, S. (2013) · Phytotherapy Research · doi:10.1002/ptr.5015 · Cited by 84
Lee, W., Cheung, C. C. M., Liu, K. W. K., Fung, K., Wong, J., Lai, P. B. S., & Yeung, J. H. K. (2010) · Journal of Natural Products · doi:10.1021/np900792p · Cited by 83
Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells
Park, I.-J., Kim, M. J., Park, O. J., Choe, W., Kang, I., Kim, S. S., & Ha, J. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0680-3 · Cited by 82
Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice
Dong, K., Xu, W., Yang, J. J., Qiao, H., & Wu, L. (2008) · Phytotherapy Research · doi:10.1002/ptr.2615 · Cited by 82
Lu, D., Leung, Y., Cheung, C.-W., Chen, Y.-R., & Wong, K. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.046 · Cited by 80
Li, Q., Shi, S., Liu, Q., Tang, J., Song, J.-Y., & Liang, Y. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.031 · Cited by 78
Gong, Y., Li, Y., Abdolmaleky, H. M., Li, L., & Zhou, J.-R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033656 · Cited by 76
Abietane Diterpenes from Salvia miltiorrhiza Inhibit the Activation of Hypoxia-Inducible Factor-1
Đạt, N. T., Jin, X., Lee, J., Lee, D., Hong, Y., Lee, K., Kim, Y. H., & Lee, J. J. (2007) · Journal of Natural Products · doi:10.1021/np060482d · Cited by 75
Xu, D., Lin, T., Li, S., Da, J., Wen, X., Jiang, D., Chang, C., & Yeh, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.006 · Cited by 75
Pan, T., Hung, Y., Wang, P., Chen, S., Hsu, T., Sintupisut, N., Cheng, C., & Lyu, P. C. (2010) · PROTEOMICS · doi:10.1002/pmic.200900178 · Cited by 74
Lu, D., Leung, Y., Huang, S.-M., & Wong, K. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22520 · Cited by 71
Cyclooxygenase-2 and Gastric Cancer
Thiel, A., Mrena, J., & Ristimaki, A. P. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9312-1 · Cited by 70
Wen (2010) · Oncology Reports · doi:10.3892/or.2010.1107 · Cited by 68
Zhou, L., Chan, W. K. B., Xu, N., Xiao, K., Luo, H.-W., Luo, K. Q., & Chang, D. C. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.07.011 · Cited by 67
Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling
Lu, L., Li, C., Li, D., Wang, Y., Zhou, C., Shao, W., Peng, J., You, Y., Zhang, X., & Shen, X. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1711-x · Cited by 67
Self-citationKim, D. H., Kim, S., Jeon, S. J., Son, K. H., Lee, S., Yoon, B. H., Cheong, J. H., Ko, K. H., & Ryu, J. H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00378.x · Cited by 65
Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer
Lü (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000291 · Cited by 65
Zhang, Y., Won, S., Jiang, C., Lee, H., Jeong, S., Lee, E., Zhang, J., Ye, M., Kim, S., & Lü, J. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0670-3 · Cited by 65
Tanshinone�IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo
Zhong, L. (2011) · Oncology Reports · doi:10.3892/or.2011.1524 · Cited by 64
Tsai, M.-Y., Yang, R.-C., Wu, H., Pang, J. S., & Huang, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.031 · Cited by 63
Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells
Su, C. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000063 · Cited by 61
Zhao, Y., Hao, Y., Ji, H., Fang, Y., Guo, Y., Sha, W., Zhou, Y., Pang, X., Southerland, W. M., Califano, J. A., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0243 · Cited by 61
Wu, C., Hsieh, C., Huang, K., Chang, C., & Kang, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.27343 · Cited by 61
Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios
Su, C. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000030 · Cited by 60
Liu, W., Zhou, J., Geng, G., Shi, Q., Sauriol, F., & Wu, J. H. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2015292 · Cited by 59
Growth Inhibition and Apoptosis Induction by Tanshinone IIA in Human Colon Adenocarcinoma Cells
Su, C., Chen, G., Kang, J., & Chan, M. (2008) · Planta Medica · doi:10.1055/s-2008-1081299 · Cited by 58
Tian, H., Yu, T., Xu, N.-N., et al. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.020 · Cited by 58
Induction of Apoptosis by Tanshinone I via Cytochrome c Release in Activated Hepatic Stellate Cells
Kim, J. Y., Kim, K. M., Nan, J., Zhao, Y. Z., Park, P., Lee, S. J., & Sohn, D. H. (2003) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2003.920410.x · Cited by 57
Won, S., Lee, H., Jeong, S., Lü, J., & Kim, S. (2011) · Phytotherapy Research · doi:10.1002/ptr.3616 · Cited by 56
Cell Death Pathways in Response to Antitumor Therapy
Portugal, J., Bataller, M., & Mansilla, S. (2009) · Tumori Journal · doi:10.1177/030089160909500401 · Cited by 55
Zhang, Y., Wei, R., Zhu, X., Cai, L., Jin, W., & Hu, H. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834e5592 · Cited by 54
Cryptotanshinone enhances TNF-α-induced apoptosis in chronic myeloid leukemia KBM-5 cells
Kim, J., Jeong, S., Kwon, T., Yun, S., Jung, J. H., Kim, M., Lee, H., Lee, M., Ko, S., Chen, C., et al. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0605-1 · Cited by 52
Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma
Li, Q., Wang, Y., Feng, N., Fan, Z., Sun, J., & Nan, Y.-L. (2008) · Journal of drug targeting · doi:10.1080/10611860802374303 · Cited by 50
Self-citationSashidhara, K. V., Rosaiah, J. N., Kumar, M., Gara, R. K., Nayak, V. L., Srivastava, K., Bid, H. K., & Konwar, R. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.040 · Cited by 50
Tung, Y., Chen, H., Lee, C.-Y., Chou, Y.-C., Lee, P.-Y., Tsai, H.-C., Lin, Y., & Chen, C. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/319247 · Cited by 49
Tang, C., Xue, H.-L., Huang, H., & Wang, X.-G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.069 · Cited by 49
Wei, J., Xie, G., Ge, S., Qiu, Y., Liu, W., Lü, A., Chen, T., Li, H., Zhou, Z., & Jia, W. P. (2011) · Journal of Proteome Research · doi:10.1021/pr2009725 · Cited by 47
Salvianolic Acid B, a Potential Chemopreventive Agent, for Head and Neck Squamous Cell Cancer
Zhao, Y., Guo, Y., & Gu, X. (2010) · Journal of Oncology · doi:10.1155/2011/534548 · Cited by 47
Danshen (Chinese medicinal herb) preparations for acute myocardial infarction
Wu, T., Ni, J., & Wei, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004465.pub2 · Cited by 44
Zhou, Z., Yang, Y., & Ge, J.-P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi271 · Cited by 42
Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells
Dai, Z.-K., Qin, J., Huang, J.-E., Luo, Y., Xu, Q. R., & Zhao, H. (2011) · Journal of Natural Medicines · doi:10.1007/s11418-011-0576-0 · Cited by 41
Chen, L., Zheng, S., Sun, Z., Wang, A., Huang, C., Punchard, N. A., Huang, S., Gao, X., & Lu, Y. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1440-8 · Cited by 38
Su (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000476 · Cited by 38
Yang, Y., Ge, P. J., Jiang, L., Li, F. L., & Zhu, Q. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-54 · Cited by 37
Preparation, Characterization and Cytotoxicity Evaluation of Tanshinone IIA Nanoemulsions
Chang, L.-C., Wu, C.-L., Liu, C.-W., Chuo, W., Li, P., & Tsai, T. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1315 · Cited by 35
Tanshinone IIA arrests cell cycle and induces apoptosis in 786-O human renal cell carcinoma cells
Wei, X., ZHOU, L., HU, L., & Huang, Y. (2012) · Oncology Letters · doi:10.3892/ol.2012.626 · Cited by 34
Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells
Wang, Q., Wu, Q. K., Tao, Y., Liu, C., & El-Nezami, H. S. (2011) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(11)60085-4 · Cited by 32
The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells
Xu, D., Lin, T., Zhang, C., Tsai, Y., Li, S., Zhang, J., Yin, M., Yeh, S., & Chang, C. (2011) · The Prostate · doi:10.1002/pros.21474 · Cited by 28
Soares, J., Keppler, B. R., Wang, X., Lee, K., & Jarstfer, M. B. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.112 · Cited by 21
Long, X., Zhang, J., Zhang, Y., Yao, J., Cai, Z., & Yang, P. (2011) · Molecular BioSystems · doi:10.1039/c0mb00343c · Cited by 17
Blocking the DNA Repair System by Traditional Chinese Medicine?
Sun, M.-F., Chang, T.-T., Chang, K., Huang, H.-J., Chen, H., Tsai, F., Lin, J., & Chen, C. Y. (2011) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2011.10508616 · Cited by 15
Zhong, Z., Chen, W.-G., Yong-he, L., Li, Q.-X., & Qiu, Y. (2007) · PubMed · Cited by 10
Wang, L., Pan, S., Chen, T., Dong, Y., Lee, K., & Teng, C. (2012) · ChemBioChem · doi:10.1002/cbic.201200191 · Cited by 9
[The variation of Caspase3 activity in tanshinone induced NB4 cells apoptosis].
Liang, X., Yang, Y., Deng, C., et al. (2003) · PubMed · Cited by 6
Apoptosis of SGC7901 gastric cancer cell induced by Tanshinone IIA and the primary mechanisms
Chen, J. (2007) · Fudan xuebao. Yixue ban · Cited by 2
Cited by
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics
Li, Z.-M., Xu, S.-W., & Liu, P.-Q. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.193 · Cited by 564
Chen, L., Yang, Q., Zhang, H., Wan, L., Xin, B., Cao, Y., Zhang, J., & Guo, C. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113066 · Cited by 39
Recent advances of tanshinone in regulating autophagy for medicinal research
Wu, S., Zhao, K., Wang, J., Liu, N., Nie, K., Qi, L., & Xia, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059360 · Cited by 32
Kim, N. Y., Jung, Y. Y., Yang, M. H., Chinnathambi, A., Govindasamy, C., Narula, A. S., Namjoshi, O. A., Blough, B. E., & Ahn, K. S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.018 · Cited by 24
Metadata
- Authors
- Chen, X., Guo, J., Bao, J., Lu, J., & Wang, Y.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2013-10-07
- Volume
- 34
- Issue
- 4
- Pages
- 768-794
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W1821806054
- Cited by
- 279
- References
- 80
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.